Title of Invention

METHOD FOR PRODUCING POLYMERS INCORPORATING LIVING MATERIAL

Abstract

Method for producing hydrophobic polymers, wherein - a hydrophobic polymer is selected; - a set of organisms is selected from among cells and/or cell products; - aggregates are formed by working said cells and/or cell products in said polymers resulting in the formation of a so-called polymer-bio aggregate, wherein there is performed a new function of the thus polymer product. This invention further relates to the use of a so-called P.B.A. obtained therewith in specific applications.

Full Text

Process for manufacturing hydrophobic polymers 5 Field of the invention The present invention relates to a method for producing hydrophobic polymers incorporating living organisms and/or cell products. 10 Prior art This type of method is known for non-permanent, biodegradable hydrophilic polymers with a melting point well below 1000C, in which temperature-sensitive tissue cells and organic molecules are incorporated. The polymer degrades after a 15 short time. American patent US-5,985,354 in the name of MATHIOWITZ describes a method of the above type. The problem encountered in the known prior art is that the melting point of permanent, non-biodegradable polymers is well above 1000C at 20 normal pressure conditions for the incorporation of living material. The implantation of living, active organisms or microorganisms at temperatures of this level is impossible without fatal consequences for these organisms. Accordingly, it has to be assumed that the incorporation of living material during the production of a usable object from the base material, in this case the polymer, is not achievable, 25 even if the organisms which are introduced can subsequently perform useful activity at normal ambient temperatures. Possible activities in this respect are oxygen consumption or absorption, absorption of radiant energy, including what is known as "UV blocking", and the like. The above therefore demonstrates that currently there are considerable restrictions in the possible range of applications 30 for living cells in this type of polymer. A further problem encountered in the known prior art is that the slow diffusion of cellular components and biomolecules in a moist environment is based on a technology which is predicated on multi-wall microcapsules of hydrophilic, soluble 35 or biodegradable polymers. However, there is currently no available technology which permits the slow diffusion of a gamma to biomolecules from a permanent - 2 - polymeric carrier without it being degraded in an aqueous and/or dry environment. This applies in particular to biomolecules of the hydrophobic fatty acid type, such as lipids and hydrocarbons. 5 Therefore, the known prior art mainly has the following shortcoming, namely that bio-encapsulation of cells in polymers is not possible above 1000C under standard pressure conditions, on the one hand, and that slow diffusion of cellular metabolites and related organic molecules from polymers is not possible without degradation of the polymer in a moist environment, on the other hand. 10 Object of the invention It is an object of the present invention to offer a solution to the abovementioned drawbacks and/or shortcomings. 15 Summary of the invention According to the present invention, there is proposed a method for producing hydrophobic polymers in which a hydrophobic polymer is selected, and 20 furthermore a set of organisms is selected from cells and/or cell products. Remarkably, aggregates are then formed by working the said cells into the said polymer, resulting in the formation of what is known as a polymer-bio aggregate, referred to below as PBA, producing a novel function of the polymer product formed in this way. 25 According to a preferred embodiment of the invention, further to the main measure defined above, there is defined that the work is carried out in the operating temperature range taken from the temperature range for which the lower limit is set at virtually 1000C under virtually standard pressure conditions, in particular at 30 virtually one atmosphere. According to a further preferred embodiment of the invention, there is defined that the abovementioned cells are selected from the category of what are known as the cysts and/or in a phase of inactive or dormant stages. A quite significant number 35 of types of organisms or microorganisms can change from an active life form to what is known as a quiescent stage or spore, known as cysts. Said spores are - 3 - able to withstand extreme environmental fluctuations in a latent form. In this state of anabiosis, they are able to withstand extremely dry conditions and temperatures well above 1000C. 5 Under suitable biotechnology conditions, these types can not only be cultivated but also converted, in controlled culture conditions, known an encysting, into usable spores for bio-encapsulation in a polymeric matrix. During the production process of an industrial product, such as packaging 10 material, textile fibers, granules or the like, said spores and the polymer are agglomerated within a short period of time during which the polymer is liquid, namely at a temperature above its melting point. This produces what is known as a polymer-bio aggregate, referred to below as "PBA". 15 As long as the product is not in use, the organisms of the bio-component in said PBA remain inactive. However, as soon as the living conditions become favorable, coinciding with the product starting to be used in association with an environment which is suitable for life in terms of temperature and relative humidity, the spores change into active, metabolizing cells under these favorable ambient conditions. 20 For this period, the biologically active form will perform its intended function. As soon as the optimum conditions revert to conditions which are less than optimum, the active form returns to the spore. The process remains reversible in accordance with a feedback mechanism which 25 is controlled by the living environment of the organism in said PBA. Thus, according to a particularly preferred embodiment of the invention, said cell products are selected from the category of so-called metabolites, i.e. the molecules which are biochemically synthesized by organisms under the 30 abovementioned temperature working conditions. According to yet another preferred embodiment of the present invention, the polymers are selected from non-biodegradable polymers. Reliable, slow and prolonged diffusion of organic molecules out of polymers into a moist or fluctuating 35 environment can be realized without degradation of the polymer. - 4 - An advantage obtained by virtue of the method defined by the present invention is mainly that the biological activity of the organisms incorporated in the so-called PBA produced in accordance with the invention imparts novel, previously unknown properties to the polymer. Said PBA hereby ensures the desired environment for 5 which said PBA was made. A further advantage consists in the standardized release of very specific biomolecules, such as so-called repellents, from a polymeric matrix, such as granules, textile fibers and the like, without said polymeric matrix being lost in a 10 variable environment as a result of climatological instabilities, for example. Further features and properties of the present invention are defined in further sub- claims. 15 Further details and particularities will emerge from the following description of a number of exemplary embodiments of the method according to the invention and its uses. Description 20 In general terms, the present invention relates to a method for producing hydrophobic polymers which incorporate living organisms and/or cell products. A number of specific use examples are described below. 25 A particularly significant application area is in the food packaging sector which employs what is known as an oxygen barrier, with a PBA layer arranged as an intermediate layer in multi-layer packaging material for foodstuffs, such as PET bottles for beverages, such as beers or fruit juices for example. The polymer component of the PBA is in this case PET, while the PBA bio component is a type 30 of yeast with a dry spore, such as for example Saccharomyces, which is able to withstand the high temperatures of the production process. The PBA remains inactive until the PET bottle has been filled. When the package is being filled with fruit juices or beer, for example, the internal environment of the PBA becomes water-saturated, with the result that the spores are activated to form respiring cells 35 which consume all the oxygen present inside the bottle. As a result, all the oxygen is withdrawn from the contents under the influence of what is known as the O2 ~~ 5 ~ scavenger. Also, all the external oxygen which can diffuse through the wall is captured by the yeast cells for respiration, which results in an efficient oxygen barrier. 5 A further example of a use consists in the action as a UV blocker, which works in a similar way to the above example. Instead of the yeast cells, there is incorporated in the PBA a type of alga, such as for example Haematococcus, the spores of which very intensively block UV light. A continuous layer of Haematococcus cells, haematocysts with a high concentration of astaxanthin, makes the PBA opaque to 10 UV light. This fact is utilized in moisture-resistant UV-proof films and polymer coverings. A still further use consists in the combined application of both examples mentioned above in connection with food packaging with an oxygen barrier and a 15 UV blocker which is suitable for PET bottles as packaging for beers and fruit juices and the like. The PBA biocomponent is a calibrated mixture of Saccharomyces and Haematococcus. Said oxygen scavengers, such as yeast cells for example, represent a permanent oxygen barrier, while the UV blocker, such as a type of alga, for example, prevents photochemical degradation of the filling. 20 Yet another application consists in the absorption of energy from sunlight with a cooling effect which is similar to the example above relating to the so-called UV blocker. Instead of Haematococcus, the PBA incorporates a type of alga such as for example Chlorococcus, the active form of which, in the presence of a high 25 degree of moisture, participates very intensively in photosynthesis, consuming high-energy rays of the sunlight. A continuous layer of cells will provide the PBA with an energy-absorbing function, resulting in a non-heating, in other words cooling, effect at the bottom of the polymer. The above effect is utilized in moisture-resistant films and polymer coverings for sun-shielding purposes. 30 Finally there is the application example ranging from energy-absorbing cloth to perspiration-sensitive sports clothing which derives from the previous example. A PBA with a polymer component of polypropylene and a biocomponent of photosynthesizing organisms, such as a cyanobacterium or a unicellular alga type, 35 is extruded to form a textile fiber. The temperature-resistant spores of the algae, after they have been extruded to form a fiber, are processed to produce a textile - 6 - product. Use of fibers of this type in textile products ranges from covering fabrics, such as canvas, to sports clothing. For the absorption of moisture, for example sweat, the incorporated cells will convert the incident energy of sunlight into photosynthetic metabolites. As a result, the incident solar radiation is not 5 converted into heat, but rather is extracted from the textile fiber, resulting in the desired cooling action. When drying out when no further sweat is being produced, the cells revert to their latent, inactive state. This is because the process is reversible. 10 Application examples relating to slow diffusion of cellular components and at least partially hydrophobic biomolecules in a moist environment are described below. In a variant on the UV blocker from the above example, the active metabolite, astaxanthin, which very intensively blocks UV light, is incorporated in the PBA 15 instead of the Haematococcus cells. As an alternative to the expensive component astaxanthin, it may be possible to use less expensive UV blockers. The diffusion rate of the UV blocker from the PBA in the middle layer of the polylamellar film to the periphery is regulated at a low to very low diffusion rate, depending on the quality and requirements. This fact is exploited in moisture-resistant UV-repellent 20 films and polymer coverings, as well as for packaging material for food products. The polymer must in this case be durable and must not deteriorate in moist conditions. In this context, an additional example of application consists in insect-repellent 25 films, fibers - textile - and microgranules. This represents a variant on the above example. In this case, the bio component of the PBA is a bio-active organic molecule or a mixture of molecules, preferably hydrophobic substances, such as lipids, fatty acids, isoprene derivatives and hydrocarbons. In addition to a film or laminate, the processed product may also be a PBA which is processed to form a 30 textile fiber or granule or microgranule, in which the biocomponent is released to the environment at a predetermined rate. This component has a specific repellent action to insects. Examples which have been tested include: PBA with isoprene derivates and/or branched hydrocarbons with a repellent activity to house dust mites. The PBA is extruded to form a textile fiber for weaving 35 a fixed carpet and other products which have to be resistant to house dust mites; and - 7 - PBA with fatty acid components which are repellent to diptera, namely flies and mosquitoes, and biting and blood-sucking lice, Mallophaga, Anoplura, respectively, as well as the human head louse and poultry lice, cockroaches, ants and wasps. The PBA is granulated or extruded to form a textile fiber. The laden 5 granules are mixed into the animal's coat, to protect against myiasis, horsefly and the like, or are scattered on the nesting site of the host of the parasite in question. Laden fibers are processed to form a protective textile as a nightcap to kill head lice, or what is known as a tissue with which an object can be rubbed to protect against ants, cockroaches, flies and the like. 10 Further to the above example, another important application is the use of the PBAs as a crop protection agent, in particular as a herbicide or even as a fungicide. 15 The biological activity of the organisms incorporated in the PBA gives the polymer new properties which were not previously known. The PBA ensures the desired environment for which the PBA was made, such as for example an anaerobic environment, complete oxygen barrier, energy absorption of solar radiation, controlled release of metabolites and the like. 2 0 The interaction and exchange of various types of organisms or microorganisms and/or molecules in the bio component of the PBA can also yield a large number of possible applications. CLAIMS 1. Method for producing hydrophobic polymers, wherein 5 - a hydrophobic polymer is selected ; - a set of organisms is selected from among cells and/or cell products ; - aggregates are formed by working said cells and/or cell products in said polymers resulting in the formation of a so-called polymer-bio aggregate, wherein there is performed a new function of the thus produced polymer product. 10 2. Method according to the preceding claim, characterized in that work is carried out at the working temperature range taken from the temperature interval of which the lower limit is set at substantially 1000C under substantially standard pressure conditions, in particular at substantially one atmosphere. 15 3. Method according to the preceding claim, characterized in that said cells are selected from among the category of the so-called cysts and/or in a phase of inactive or sleeping stages. 20 4. Method according to one of the preceding claims, characterized in that the cells are selected from among the prokaryotes, in particular bacteria, and/or eukaryotes. 5. Method according to the preceding claim, characterized in that the cells are 25 selected from among the eukaryotes of the type protists, fungi, plants, and/or animals. 6. Method according to one of the claims 2 to 5, characterized in that said cells products are selected from among the category of the so-called metabolites, 30 being the molecules which are biochemically synthesized by organisms. 7. Method according to one of the claims 2 to 5, characterized in that said organisms are unicellular. 35 8. Method according to one of the claims 1 to 6, characterized in that said organisms are multicellular. - 9 - 9. Method according to one of the preceding claims, characterized in that the polymers are selected from among non-biodegradable polymers. 5 10. Method according to one of the preceding claims, characterized in that the polymers are selected from among the family of the polyolefins. 11. Method according to the preceding claim, characterized in that the polymers are selected from among the family of the polyethylenes. 10 12. Method according to the preceding claim, characterized in that PET is selected from among the polymers. 13. Method according to claim 10, characterized in that the polymers are 15 selected from among the family of the polypropyienes. 14. Method according to one of the claims 1 to 9, characterized in that the polymers are selected from among the family of the polyesters. 2 0 15. Method according to one of the preceding claims, characterized in that said cells and/or cell products are imbedded in said polymer. 16. Method according to one of the preceding claims, characterized in that said biopolymer is obtained from bringing up the cells and/or cell products while 25 producing the polymer itself, wherein said biopolymer is obtained from a synthesis of said basis products. 17. Method according to one of the preceding claims 1 to 15, characterized in that said cells and/or cell products are blended into an existing polymer wherein 30 said blending is performed thermally. 18. Method according to one of the preceding claims 1 to 15, characterized in that said cells and/or cell products are blended in an existing polymer wherein said blending is performed warm as intermediate layer. 35 19. Method according to one of the preceding claims 3 to 18, characterized in - 10 - that the spores and the polymer are agglomerated within a short period of time during which the polymer is liquid, i.e. with its temperature above its melting point. 20. Method according to one of the preceding claims 1 to 15, characterized in 5 that said cells and/or cell products are blended into an existing polymer wherein said blending is performed cold as intermediate layer. 21. Method according to one of the preceding claims, characterized in that a so-called PBA layer is arranged as an intermediate layer in a multilayer packaging 10 material for foodstuffs, in particular PET bottles for beverages. 22. Method according to the preceding claim, characterized in that the polymer component of the so-called PBA is composed of PET, whereas the so-called PBA biocomponent is a type of yeast with a dry spore, which is able to withstand the 15 high temperatures of the production process. 23. Method according to the preceding claim, characterized in that instead of, and/or possibly in combination with the yeast cells, there is incorporated a type of alga in the PBA, the spores of which block UV-light very intensively. 2 0 24. Use of the polymer - bio - aggregate obtained according to a process as defined in one of the preceding claims, as a barrier. 25. Use of the polymer - bio - aggregate obtained according to a process as 25 defined in one of the claims 1 to 20 , as an insect - repellent agent. 26. Use of the polymer - bio - aggregate obtained according to a process as defined in one of the claims 1 to 20, as a crop protection agent, in particular as a herbicide. 30 27. Use of the polymer - bio - aggregate obtained according to a process as defined in one of the claims 1 to 20, as a fungicide. Method for producing hydrophobic polymers, wherein - a hydrophobic polymer is selected; - a set of organisms is selected from among cells and/or cell products; - aggregates are formed by working said cells and/or cell products in said polymers resulting in the formation of a so-called polymer-bio aggregate, wherein there is performed a new function of the thus polymer product. This invention further relates to the use of a so-called P.B.A. obtained therewith in specific applications.

Documents:

01150-kolnp-2007-abstract.pdf

01150-kolnp-2007-claims.pdf

01150-kolnp-2007-correspondence others 1.1.pdf

01150-kolnp-2007-correspondence others.pdf

01150-kolnp-2007-description complete.pdf

01150-kolnp-2007-form 1.pdf

01150-kolnp-2007-form 3.pdf

01150-kolnp-2007-form 5.pdf

01150-kolnp-2007-gpa.pdf

01150-kolnp-2007-international publication.pdf

01150-kolnp-2007-priority document.pdf

1150-KOLNP-2007-(10-02-2012)-CORRESPONDENCE.pdf

1150-KOLNP-2007-(14-12-2011)-ABSTRACT.pdf

1150-KOLNP-2007-(14-12-2011)-AMANDED CLAIMS.pdf

1150-KOLNP-2007-(14-12-2011)-DESCRIPTION (COMPLETE).pdf

1150-KOLNP-2007-(14-12-2011)-EXAMINATION REPORT REPLY RECEIVED.pdf

1150-KOLNP-2007-(14-12-2011)-FORM-1.pdf

1150-KOLNP-2007-(14-12-2011)-FORM-13.pdf

1150-KOLNP-2007-(14-12-2011)-FORM-2.pdf

1150-KOLNP-2007-(14-12-2011)-FORM-3.pdf

1150-KOLNP-2007-(14-12-2011)-OTHER PATENT DOCUMENT.pdf

1150-KOLNP-2007-(14-12-2011)-OTHERS.pdf

1150-KOLNP-2007-CORRESPONDENCE.pdf

1150-KOLNP-2007-DECISION.pdf

1150-KOLNP-2007-EXAMINATION REPORT.pdf

1150-KOLNP-2007-FORM 13.pdf

1150-KOLNP-2007-FORM 18-1.1.pdf

1150-kolnp-2007-form 18.pdf

1150-KOLNP-2007-GPA.pdf

1150-KOLNP-2007-GRANTED-ABSTRACT.pdf

1150-KOLNP-2007-GRANTED-CLAIMS.pdf

1150-KOLNP-2007-GRANTED-DESCRIPTION (COMPLETE).pdf

1150-KOLNP-2007-GRANTED-FORM 1.pdf

1150-KOLNP-2007-GRANTED-FORM 2.pdf

1150-KOLNP-2007-GRANTED-FORM 3.pdf

1150-KOLNP-2007-GRANTED-FORM 5.pdf

1150-KOLNP-2007-GRANTED-LETTER PATENT.pdf

1150-KOLNP-2007-GRANTED-SPECIFICATION-COMPLETE.pdf

1150-KOLNP-2007-INTERNATIONAL PUBLICATION.pdf

1150-KOLNP-2007-OTHERS.pdf

1150-KOLNP-2007-PETITION UNDER RULE 137.pdf

1150-KOLNP-2007-REPLY TO EXAMINATION REPORT.pdf